Testing Gene PilotLX With Latinx Cancer Patients
ConditionCancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorFox Chase Cancer Center
About this trial
This is a randomized controlled trial designed to evaluate the efficacy of an electronic health decision support tool called Gene PilotLX to increase informed decision making regarding hereditary risk information from tumor genomic profiling (TGP) test among Latinx cancer patients recruited at four cancer centers.
Eligibility criteria
Qualifiers
diagnosed with solid tumor cancers
speak/read English or Spanish;
can provide informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Gene PilotLX
Treatment groups
232 Participants
are divided into 2 treatment groupsSponsors and collaborators
Fox Chase Cancer Center
Lead sponsor
Temple University
Collaborator
MD Anderson Cancer Center at Cooper
Collaborator
Herbert Irving Comprehensive Cancer Center
Collaborator
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov